MobileODT

Info

Contact Ariel Beery

Title CEO

Description

MobileODT uses mobile phones to detect cancer and other diseases. A 2015 SXSW Accelerator Finalist and winner of Vodafone’s 2014 Wireless Innovation Project, our flagship product is a low-cost Mobile Colposcope and end-to-end electronic clinician support system used to support cervical cancer screening and sexual assault documentation in low-resource settings worldwide.

Company News

Israeli AI FemTech solution secures prestigious US cancer grant of $2.3M to advance women's health (featuring MobileODT)

DateJan 25, 2021

MobileODT, an Israeli FemTech startup focusing on AI-powered cervical screening, has caught the eye of the US National Cancer Institute (NCI), with the NCI awarding Mobile ODT with a $2.3 million grant. The Small Business Innovation Research Authority grant is given by the NCI to companies that are technologically and clinically reducing the suffering from cancer.

Prospective Pilot Shows AI to Have Higher Accuracy in Detecting Cervical Cancer Than Lab Tests

DateApr 4, 2019

Machine Learning Algorithm Detects Cervical Cancer

DateJan 24, 2019

MobileODT and partners to launch first wide-scale deployment of AI screening for Cervical Cancer

DateJan 7, 2019

11 Israeli Startups You Should Know

DateJun 5, 2017

Back in 2015, I ran an article about 10 innovative Israeli startups to watch, compiled from my discussions with Hillel Fuld and others who follow the Israeli startup scene. It is now 2017, and I have assembled a new list of Israeli firms to watch. (Please note that I have specifically avoided including any information-security related businesses in this list as I cover cybersecurity firms in other pieces.)

MobileODT Awarded FDA Clearance

DateDec 19, 2016